NF2 and lung carcinoma: A recent lung cancer transcriptome meta-analysis showed that several HIPPO pathway component (NF2, LATS1, PTPN14, YAP1, TAZ, TAOK, and FAT1) genes were found to fuse in lung carcinoma, and they were independent prognosis factors for low lung cancer survival [43].